AI can predict the future upcoming bioink to print organs

This video shows PolyInks®-PLCL-M bioink for polymer 3D bioprinting. As a synthetic polymer that controls biodegradability by mixing PolyInks®-PLA and PolyInks®-PCL polymer bioink, it is applied to a variety of studies including tissue engineering, 3D bioprinting and drug transporters. Biodegradation period of PolyInks®-PLCL-M is 6-10 weeks.

INNOREGEN, Inc. (Bioink Solution, Inc.) is developing bioink that makes artificial organs with 3D bio printers, and aims to utilize bioink to develop medical and regenerative medicine products and ultimately artificial organs. Developing artificial organs to replace organ transplants is the dream of medical scientists to change the paradigm of medicine. Recently, research is being made to realize this dream in the fields of regenerative medicine and tissue engineering, and studies related to 3D bioprinting and bioink are closest to the development of artificial organs. In the future when this dream becomes a reality, we will be able to implant artificial organs made with 3D bioprinting directly in the operating room. INNOREGEN, Inc. (Bioink Solution, Inc.) is developing bioink for 3D bioprinting needed for artificial organ research and development, which is the dream of medical scientists. We are already launching bioinks containing animal-derived gelatin, collagen and extracellular matrix, which are biocompatible natural materials, and developing Xeno-free bioinks using human-derived gelatin, collagen, fibrin, and extracellular matrix with excellent human fit. Using this bioink development technology, we will develop bioink for artificial organ production that can be applied to human body in the future. Bioink Solution, Inc. will always openly collaborate and support with medical scientists who are studying artificial organ development through 3D bioprinting.

The Allevi Skin Bioink Kit allows you to easily bioprint custom skin tissue in your lab.